Changzhou Qianhong Biopharma Co Ltd
SZSE:002550
Changzhou Qianhong Biopharma Co Ltd
Pre-Tax Income
Changzhou Qianhong Biopharma Co Ltd
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
Changzhou Qianhong Biopharma Co Ltd
SZSE:002550
|
Pre-Tax Income
¥218m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-3%
|
CAGR 10-Years
0%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Pre-Tax Income
¥3.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Pre-Tax Income
¥3.6B
|
CAGR 3-Years
20%
|
CAGR 5-Years
20%
|
CAGR 10-Years
21%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Pre-Tax Income
¥4.8B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
0%
|
CAGR 10-Years
12%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Pre-Tax Income
¥5B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
0%
|
CAGR 10-Years
6%
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Pre-Tax Income
-¥769m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Changzhou Qianhong Biopharma Co Ltd's Pre-Tax Income?
Pre-Tax Income
218m
CNY
Based on the financial report for Mar 31, 2024, Changzhou Qianhong Biopharma Co Ltd's Pre-Tax Income amounts to 218m CNY.
What is Changzhou Qianhong Biopharma Co Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
0%
Over the last year, the Pre-Tax Income growth was -30%.